UnknownNot Applicable

Real Word European Registry of NTRK Fusions and Other Rare Actionable Fusions (TRacKING)

Austria, Czechia, Denmark500 participantsStarted 2021-06-22

Plain-language summary

This registry will make it possible to describe real life management of patients with rare actionable fusions and to better understand these cancers. In addition of clinical data from the medical files, a quality of life questionnaire (QLQ-C30) will be complete at inclusion, at each new treatment and then every 6 months. The patients will be followed for a period of at least 2 years after the inclusion. This TRacKING registry is a European collaborative tool to improve the management of patients with actionable fusions, by sharing of data from rare tumor indications.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient with histologically-confirmed cancer * Patient harboring a rare actionable fusion (see Appendix 1), * Availability of clinical and demographic data, information on treatment and clinical outcome. * Adult, ≥18 years old, * Patient should understand, sign and date the written voluntary informed consent form. Exclusion Criteria: \-

What they're measuring

Overall Survival

Timeframe: 2 years

Trial details

NCT IDNCT04921553

SponsorCentre Leon Berard

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-06

Contact for this trial

Julien Bollard

04 78 78 28 28 julien.bollard@lyon.unicancer.fr

View on ClinicalTrials.gov More Cancer trials